Boosterz Subsidiary's GIPPEUN Ranks No. 1 Overall on Wadiz Opening Day... Early Bird Packages Sell Out

"GIPPEUN", the skincare brand launched by Boosterz—a subsidiary of FSN—marked a strong start by simultaneously ranking No. 1 in both the real-time overall best and the beauty category on Wadiz crowdfunding platform on the first day of its main funding round.

FSN, a KOSDAQ-listed company, announced that its subsidiary Boosterz’s Skin Longevity brand GIPPEUN began its main funding on Wadiz on July 22. As of 1 p.m. on the opening day, it achieved the No. 1 spot in the real-time overall best ranking and the No. 1 in the beauty category.

GIPPEUN kicked off its main funding at 11 a.m. that day, and within just five minutes after sales started, all three types of its limited “early bird packages” were sold out. The company explained that, in response to the high demand, it urgently secured additional stock and confirmed strong market interest through its first official sales event.

This outcome is considered meaningful as it was achieved during the brand’s very first official sales. During the pre-launch period on Wadiz, GIPPEUN operated a product trial group to gather early consumer reactions and product feedback. Now, through the main funding, it is validating market demand with real purchase data. The brand’s strategy is to build credibility by sequentially verifying the market—from initial trials to actual sales.

GIPPEUN is a skincare brand celebrating “Skin Longevity” as its core value, aiming to help maintain natural skin health for a long time. Existing high-performance serums were often critiqued for insufficient delivery of active ingredients, while spicule-based products were said to be used less frequently due to irritation. Dermatology treatments, meanwhile, are limited for everyday care because of cost, pain, and recovery periods.

To address this, GIPPEUN applied its ultra-fine spicule technology, “NEO SHOT”, which provides both low irritation and high absorption. Its signature product, the “NEO SHOT Skin Boost Serum”, proposes a high-performance skincare solution suitable for daily use while reducing irritation.

Boosterz is strategically utilizing Wadiz as a platform for early market validation and to expand consumer touchpoints. It plans to incorporate purchase data and consumer feedback gathered on Wadiz into product development and brand management. Based on these insights, Boosterz aims to expand distribution through its own online mall, direct-to-consumer (D2C) channels in Korea, and global e-commerce markets.

A spokesperson from Boosterz stated, “In the early days of a brand launch, actual consumer choices and evaluations are a more important indicator of brand growth than sales volume itself. The results of the first-day sales and our high ranking on the platform reflect the strong market interest in the new skincare experience offered by GIPPEUN.”

They added, “We will continue to enhance our product competitiveness based on the consumer feedback secured through Wadiz, and grow GIPPEUN into a skin longevity brand with a presence not only in the Korean market but also globally.”

GIPPEUN is operated by the brand house BFINITY. BFINITY is a joint venture established by FSN’s subsidiary Boosterz and B&—a company specializing in cosmetic technologies such as NEO Spicule. Boosterz provides support in advertising, marketing, and financial investments for promising brands. In 2025, it recorded consolidated sales of 199.3 billion won and an operating profit of 33.4 billion won.

GIPPEUN has proven its potential for success and completed its initial market validation through its first official sales on Wadiz. Building on this foundation, the company plans to accelerate distribution expansion and brand growth both domestically and overseas.

This content was produced with the assistance of AI translation services.